van Baal Mark C, van Rens Michiel J, Geven Christopher B, van de Pol Francien M, van den Brink Ilona W, Hannink Gerjon, Nagtegaal Iris D, Peters Wilbert H, Rijkers Ger T, Gooszen Hein G
Dept. Operating Rooms/Evidence Based Surgery, Radboudumc, Nijmegen, The Netherlands.
Dept. Operating Rooms/Evidence Based Surgery, Radboudumc, Nijmegen, The Netherlands.
Pancreatology. 2014 Nov-Dec;14(6):470-7. doi: 10.1016/j.pan.2014.10.002. Epub 2014 Oct 16.
BACKGROUND/OBJECTIVES: Recently, a randomized controlled trial showed that probiotic prophylaxis was associated with an increased mortality in enterally fed patients with predicted severe pancreatitis. In a rat model for acute pancreatitis, we investigated whether an association between probiotic prophylaxis and enteral nutrition contributed to the higher mortality rate.
Male Sprague-Dawley rats were allocated to four groups: 1) acute pancreatitis (n = 9), 2) acute pancreatitis and probiotic prophylaxis (n = 10), 3) acute pancreatitis and enteral nutrition (n = 10), and 4) acute pancreatitis, probiotic prophylaxis and enteral nutrition (n = 11). Acute pancreatitis was induced by intraductal glycodeoxycholate and intravenous cerulein infusion. Enteral nutrition, saline, probiotics and placebo were administered through a permanent jejunal feeding. Probiotics or placebo were administered starting 4 days before induction of pancreatitis and enteral nutrition 1 day before start until the end of the experiment, 6 days after induction of pancreatitis. Tissue samples and body fluids were collected for microbiological and histological examination.
In all animals, serum amylase was increased six hours after induction of pancreatitis. After fulfilling the experiment, no differences between groups were found in histological severity of pancreatitis, degree of discomfort, weight loss, histological examination of small bowel and bacterial translocation (all p > 0.05). Overall mortality was 10% without differences between groups (p = 0.54).
No negative association was found between prophylactic probiotics and enteral nutrition in acute pancreatitis. No new clues for a potential mechanism responsible for the higher mortality and bowel ischaemia in the PROPATRIA study were found.
背景/目的:最近,一项随机对照试验表明,在预计患有严重胰腺炎的肠内喂养患者中,预防性使用益生菌与死亡率增加有关。在急性胰腺炎大鼠模型中,我们研究了预防性使用益生菌与肠内营养之间的关联是否导致了更高的死亡率。
将雄性Sprague-Dawley大鼠分为四组:1)急性胰腺炎组(n = 9),2)急性胰腺炎+益生菌预防组(n = 10),3)急性胰腺炎+肠内营养组(n = 10),4)急性胰腺炎+益生菌预防+肠内营养组(n = 11)。通过导管内注入甘氨胆酸钠和静脉注射雨蛙肽诱导急性胰腺炎。通过永久性空肠喂养给予肠内营养、生理盐水、益生菌和安慰剂。在胰腺炎诱导前4天开始给予益生菌或安慰剂,在胰腺炎诱导前1天开始给予肠内营养,直至实验结束,即胰腺炎诱导后6天。收集组织样本和体液进行微生物学和组织学检查。
在所有动物中,胰腺炎诱导后6小时血清淀粉酶升高。实验结束后,各组在胰腺炎组织学严重程度、不适程度、体重减轻、小肠组织学检查和细菌移位方面均无差异(所有p>0.05)。总体死亡率为10%,各组之间无差异(p = 0.54)。
在急性胰腺炎中,未发现预防性使用益生菌与肠内营养之间存在负相关。未发现PROPATRIA研究中导致较高死亡率和肠缺血的潜在机制的新线索。